These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Tiotropium for the treatment of asthma in adolescents. Hamelmann E; Vogelberg C; Szefler SJ Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558 [TBL] [Abstract][Full Text] [Related]
24. Efficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary disease. Welte T; Miravitlles M; Hernandez P; Eriksson G; Peterson S; Polanowski T; Kessler R Am J Respir Crit Care Med; 2009 Oct; 180(8):741-50. PubMed ID: 19644045 [TBL] [Abstract][Full Text] [Related]
25. Long-acting bronchodilator therapy for the treatment of chronic obstructive pulmonary disease. Chen AM; Bollmeier SG; Finnegan PM Ann Pharmacother; 2008 Dec; 42(12):1832-42. PubMed ID: 18957624 [TBL] [Abstract][Full Text] [Related]
26. [Clinical benefits of tiotropium, a new anticholinergic bronchodilator]. Izquierdo Alonso JL An Med Interna; 2002 Dec; 19(12):640-3. PubMed ID: 12593035 [TBL] [Abstract][Full Text] [Related]
27. Anticholinergics for asthma: a long history. Rodrigo GJ Curr Opin Allergy Clin Immunol; 2018 Feb; 18(1):38-43. PubMed ID: 29040210 [TBL] [Abstract][Full Text] [Related]
28. Tiotropium: a bronchodilator for chronic obstructive pulmonary disease. Somand H; Remington TL Ann Pharmacother; 2005 Sep; 39(9):1467-75. PubMed ID: 16030078 [TBL] [Abstract][Full Text] [Related]
29. Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β Buhl R; FitzGerald JM; Busse WW Respir Med; 2018 Oct; 143():82-90. PubMed ID: 30261998 [TBL] [Abstract][Full Text] [Related]
30. [Anticholinergic drugs in the therapy of obstructive airway diseases]. Windt R Med Monatsschr Pharm; 2011 Apr; 34(4):130-7. PubMed ID: 21528530 [TBL] [Abstract][Full Text] [Related]
31. The Role of Long-Acting Antimuscarinic Agents in the Treatment of Asthma. Arslan B; Çetin GP; Yilmaz İ J Aerosol Med Pulm Drug Deliv; 2023 Aug; 36(4):189-209. PubMed ID: 37428619 [TBL] [Abstract][Full Text] [Related]
32. Tiotropium improves lung function in patients with severe uncontrolled asthma: a randomized controlled trial. Kerstjens HA; Disse B; Schröder-Babo W; Bantje TA; Gahlemann M; Sigmund R; Engel M; van Noord JA J Allergy Clin Immunol; 2011 Aug; 128(2):308-14. PubMed ID: 21636120 [TBL] [Abstract][Full Text] [Related]
33. Enhanced persistence with tiotropium compared with other respiratory drugs in COPD. Breekveldt-Postma NS; Koerselman J; Erkens JA; Lammers JW; Herings RM Respir Med; 2007 Jul; 101(7):1398-405. PubMed ID: 17368011 [TBL] [Abstract][Full Text] [Related]
34. Investigating new standards for prophylaxis in reduction of exacerbations--the INSPIRE study methodology. Seemungal T; Stockley R; Calverley P; Hagan G; Wedzicha JA COPD; 2007 Sep; 4(3):177-83. PubMed ID: 17729060 [TBL] [Abstract][Full Text] [Related]
35. Anticholinergic agents for chronic asthma in adults. Westby M; Benson M; Gibson P Cochrane Database Syst Rev; 2004; 2004(3):CD003269. PubMed ID: 15266477 [TBL] [Abstract][Full Text] [Related]
36. Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients. Wielgat P; Mroz RM; Stasiak-Barmuta A; Szepiel P; Chyczewska E; Braszko JJ; Holownia A Adv Exp Med Biol; 2015; 839():1-5. PubMed ID: 25252903 [TBL] [Abstract][Full Text] [Related]
37. Efficacy of anticholinergic drugs in asthma. Novelli F; Malagrinò L; Dente FL; Paggiaro P Expert Rev Respir Med; 2012 Jun; 6(3):309-19. PubMed ID: 22788945 [TBL] [Abstract][Full Text] [Related]
38. The β-2 agonist debate: is there still a problem? Patel M; Shirtcliffe P; Beasley R Curr Opin Allergy Clin Immunol; 2013 Feb; 13(1):58-62. PubMed ID: 23037719 [TBL] [Abstract][Full Text] [Related]
39. [Effect of different therapy options on bronchial contraction in rats with modeled obstructive pulmonary disease]. Kuzubova NA; Fedin AN; Lebedeva ES; Platonova IS Ross Fiziol Zh Im I M Sechenova; 2014 Sep; 100(9):1049-58. PubMed ID: 25697013 [TBL] [Abstract][Full Text] [Related]
40. Twenty-five statements on early initiation of fixed combination ICS/LABA treatment for asthma and COPD in primary and secondary care: consensus research by a modified Delphi process. Kardos P; Bechtel B; Palovis L; Hagedorn C; Latif F Pneumologie; 2012 Sep; 66(9):549-57. PubMed ID: 22899206 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]